📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Autologous macrophage therapy for liver cirrhosis: a phase 2 open-label randomized controlled trial (2025)

First Author: Brennan P

Attributed to: Autologous Macrophage Therapy for Liver Cirrhosis funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1038/s41591-024-03406-8

PubMed Identifier: 39794616

Publication URI: http://europepmc.org/abstract/MED/39794616

Type: Journal Article/Review

Parent Publication: Nature Medicine

ISSN: 1078-8956